Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001567619-20-021287

Director bought 425,000 shares at $23.00 ($9,775,000)

  • Director acquired 638,744 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

YAO TONY DUNG LING · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-15 Conversion : show line 1 in the form +2,864 2,864 D
2020-12-15 Conversion : show line 2 in the form +455,326 455,326 I
2020-12-15 Conversion : show line 3 in the form +180,554 635,880 I
2020-12-15 Purchase : show line 4 in the form +425,000 $23.00 $9,775,000 1,060,880 I
Open-market purchases · 425,000 sh · avg $23.00 · $9,775,000

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2020-12-15 Conversion : show line 5 in the form Series B Preferred Stock −2,864 0 D
2020-12-15 Conversion : show line 6 in the form Series B Preferred Stock −455,326 0 I
2020-12-15 Conversion : show line 7 in the form Series C Preferred Stock −180,554 0 I
Loading xslF345X03/doc1.xml…